Elevated expression of fatty acid synthase is common in metastatic, castration-resistant prostate cancer, and higher levels of phospholipids containing saturated and monounsaturated fatty acids are linked with greater metastatic potential in both prostate and other cancer types (reviewed by Butler et al. (41)). The gene discussed is FASN; the disease is cancer.